{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:10:58Z","timestamp":1784650258041,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.hpb.2024.09.004","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T12:45:25Z","timestamp":1726231525000},"page":"1544-1552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The impact of lymph node ratio on survival in gallbladder cancer: a national cancer database analysis"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0974-4965","authenticated-orcid":false,"given":"Andrii","family":"Khomiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9606-9309","authenticated-orcid":false,"given":"Sumaya A.","family":"Ghaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9786-3651","authenticated-orcid":false,"given":"Salvador","family":"Rodriguez Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6742-6909","authenticated-orcid":false,"given":"Ioannis A.","family":"Ziogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Cumbler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gleisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Del Chiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Schulick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Mungo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2024.09.004_bib1","first-page":"99","article-title":"Gallbladder cancer: epidemiology and outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.hpb.2024.09.004_bib2","series-title":"Survival rates for gallbladder cancer","author":"Society","year":"2023"},{"key":"10.1016\/j.hpb.2024.09.004_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00423-020-01878-z","article-title":"Effect of lymphadenectomy in curative gallbladder cancer treatment: a systematic review and meta-analysis","volume":"405","author":"Widmann","year":"2020","journal-title":"Langenbeck\u2019s Arch Surg"},{"issue":"1 Pt B","key":"10.1016\/j.hpb.2024.09.004_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.amjsurg.2021.12.028","article-title":"Lymphadenectomy in gallbladder adenocarcinoma: are we doing enough?","volume":"224","author":"Papageorge","year":"2022","journal-title":"Am J Surg"},{"key":"10.1016\/j.hpb.2024.09.004_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jss.2020.08.041","article-title":"Gallbladder cancer surgery in the United States: lymphadenectomy trends and impact on survival","volume":"258","author":"Maegawa","year":"2021","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.hpb.2024.09.004_bib6","series-title":"AJCC cancer staging manual. 8th ed.","article-title":"Gallbladder","author":"Zhu","year":"2017"},{"key":"10.1016\/j.hpb.2024.09.004_bib7","first-page":"452","article-title":"Surgery for gallbladder cancer in the US: a need for greater lymph node clearance","volume":"6","author":"Tran","year":"2015","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/codi.12242","article-title":"The importance of lymph node retrieval and lymph node ratio following preoperative chemoradiation of rectal cancer","volume":"15","author":"Torre","year":"2013","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.hpb.2024.09.004_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s00384-023-04490-x","article-title":"Log odds of positive lymph nodes show better predictive performance on the prognosis of early-onset colorectal cancer","volume":"38","author":"Liang","year":"2023","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.hpb.2024.09.004_bib10","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/cncr.24989","article-title":"Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection","volume":"116","author":"Sun","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2024.09.004_bib11","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s11605-014-2539-8","article-title":"Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma?","volume":"18","author":"Aurello","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2024.09.004_bib12","first-page":"136","article-title":"Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer","author":"Fleming","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib13","article-title":"A\u00a0systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma","volume":"99","author":"M","year":"2016","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.hpb.2024.09.004_bib14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11605-011-1528-4","article-title":"Lymph nodal involvement as prognostic factor in gallbladder cancer: location, count or ratio?","volume":"15","author":"Negi","year":"2011","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2024.09.004_bib15","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1245\/s10434-016-5243-y","article-title":"Prognostic implications of lymph node status for patients with gallbladder cancer: a multi-institutional study","volume":"23","author":"Amini","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00423-019-01807-9","article-title":"Validation of the prognostic performance in various nodal staging systems for gallbladder cancer: results of a multicenter study","volume":"404","author":"Lee","year":"2019","journal-title":"Langenbeck\u2019s Arch Surg"},{"key":"10.1016\/j.hpb.2024.09.004_bib17","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1245\/s10434-021-10749-w","article-title":"Optimal lymph node staging system in evaluating prognosis of gallbladder carcinoma: a multi-institutional study","volume":"28","author":"Chen","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib19","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1200\/JCO.21.02568","article-title":"Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study","volume":"40","author":"Bridgewater","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (prodige 12-ACCORD 18-UNICANCER GI): a randomized phase III study","volume":"37","author":"Edeline","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib21","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1245\/s10434-020-08973-x","article-title":"Adjuvant chemotherapy in resectable gallbladder cancer is underutilized despite benefits in node-positive patients","volume":"28","author":"Kemp Bohan","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","article-title":"Overview of current targeted therapy in gallbladder cancer","volume":"5","author":"Song","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.hpb.2024.09.004_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0b013e31822238d8","article-title":"Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment","volume":"254","author":"Ito","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2024.09.004_bib24","series-title":"NCCN guidelines - biliary tract cancers v3.2023","year":"2023"},{"key":"10.1016\/j.hpb.2024.09.004_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/cco.2019.08.13","article-title":"Gallbladder cancer: epidemiology and genetic risk associations","volume":"8","author":"Schmidt","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/jso.25825","article-title":"Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: an analysis of the US extrahepatic biliary malignancy consortium","volume":"121","author":"Sahara","year":"2020","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00423-023-03119-5","article-title":"Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved","volume":"408","author":"Wang","year":"2023","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.hpb.2024.09.004_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jso.23813","article-title":"Lymph node status after resection for gallbladder adenocarcinoma: prognostic implications of different nodal staging\/scoring systems","volume":"111","author":"Amini","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib29","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1245\/s10434-021-09626-3","article-title":"Conditional recurrence-free survival after oncologic extended resection for gallbladder cancer: an international multicenter analysis","volume":"28","author":"Vega","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/SLA.0000000000000728","article-title":"Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study","volume":"261","author":"Shindoh","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2024.09.004_bib31","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1245\/s10434-017-5859-6","article-title":"Incidental gallbladder cancer: residual cancer discovered at oncologic extended resection determines outcome: a report from high- and low-incidence countries","volume":"24","author":"Vinuela","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11605-009-1140-z","article-title":"Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma","volume":"14","author":"Kim","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2024.09.004_bib33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1245\/s10434-014-4044-4","article-title":"Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio","volume":"22","author":"Birnbaum","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11605-017-3507-x","article-title":"Extended lymphadenectomy is required for incidental gallbladder cancer independent of cystic duct lymph node status","volume":"22","author":"Vega","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2024.09.004_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1477-7819-10-87","article-title":"Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes","volume":"10","author":"Shirai","year":"2012","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.suronc.2015.05.001","article-title":"Ratio and log odds of positive lymph nodes in breast cancer patients with mastectomy","volume":"24","author":"Chen","year":"2015","journal-title":"Surg Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4174\/jkss.2013.84.3.168","article-title":"Impact of lymph node ratio as a valuable prognostic factor in gallbladder carcinoma, focusing on stage IIIB gallbladder carcinoma","volume":"84","author":"Choi","year":"2013","journal-title":"J Korean Surg Soc"},{"key":"10.1016\/j.hpb.2024.09.004_bib38","doi-asserted-by":"crossref","first-page":"542005","DOI":"10.3389\/fonc.2020.542005","article-title":"Lymph node ratio-based staging system for gallbladder cancer with fewer than six lymph nodes examined","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejso.2015.10.013","article-title":"Optimal assessment of lymph node status in gallbladder cancer","volume":"42","author":"Kim","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib40","doi-asserted-by":"crossref","first-page":"16466","DOI":"10.1038\/s41598-022-20933-x","article-title":"A novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery","volume":"12","author":"Jiang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.hpb.2024.09.004_bib41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.21037\/atm.2019.11.112","article-title":"A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery","volume":"7","author":"Xiao","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.hpb.2024.09.004_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.675661","article-title":"Nomogram based on log odds of positive lymph nodes predicting cancer-specific survival in patients with T3 and T4 gallbladder cancer after radical resection","volume":"8","author":"Yuan","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.hpb.2024.09.004_bib43","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.18.02178","article-title":"Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline","volume":"37","author":"Shroff","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2024.09.004_bib44","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X24023207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X24023207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T02:17:33Z","timestamp":1764555453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X24023207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1365182X24023207"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2024.09.004","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of lymph node ratio on survival in gallbladder cancer: a national cancer database analysis","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2024.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}